President Trump’s decision to pull out of the international health agency could deprive the United States of crucial ...

Robert F. Kennedy Jr. will appear before the Senate Finance Committee for the first of two confirmation hearings as Trump’s nominee for secretary of the Department of Health and Human Services. This ...

The World Health Organization on Tuesday urged the United States to reconsider its decision to suspend funding for HIV treatment programs in developing countries, after President Donald Trump ordered ...

Abu Dhabi-based global healthcare giant M42 is at the forefront of transforming healthcare delivery by leveraging ...

Women are more likely than men to develop long COVID, a new study finds, with the highest risk in women ages 40 to 54. Women ...

Arcturus Therapeutics Holdings Inc. stock is down 46% since Sept. 2023 coverage; mRNA sector faces headwinds with public ...

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

Compared with placebo, fostamatinib did not increase the number of oxygen-free days among adults hospitalized with COVID-19 and hypoxemia.

Along with claiming the lives of 1.2 million Americans, the COVID-19 pandemic has been described as a mass disabling event.